Cargando…

Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy

Port-wine birthmark (PWB) are congenital vascular malformations that commonly occur on the face and neck, with an incidence of 0.3–0.5% in the general population, causing significant negative psychological effects and economic burden to patients. Nevertheless, amidst the plethora of different treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xu, Yang, Lihua, Zhang, Qian, Yang, Fengjuan, Jiang, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315137/
https://www.ncbi.nlm.nih.gov/pubmed/37404369
http://dx.doi.org/10.2147/CCID.S418019
_version_ 1785067452257796096
author Liu, Xu
Yang, Lihua
Zhang, Qian
Yang, Fengjuan
Jiang, Xian
author_facet Liu, Xu
Yang, Lihua
Zhang, Qian
Yang, Fengjuan
Jiang, Xian
author_sort Liu, Xu
collection PubMed
description Port-wine birthmark (PWB) are congenital vascular malformations that commonly occur on the face and neck, with an incidence of 0.3–0.5% in the general population, causing significant negative psychological effects and economic burden to patients. Nevertheless, amidst the plethora of different treatment methods for PWB, choosing the option that best suits the patient’s need can be a challenge. In recent years, traditional treatment methods for PWB have been replaced by new therapies, and radioactive nuclide patch therapy is one of them. A panel of experts sought to describe herein 4 clinical cases, illustrating the PDT can demonstrate good precision and efficacy in the treatment of PWB. The research findings show the 4 patients in this group had a history of treatment with radioactive isotope patches. After 2–3 sessions of HMME-PDT, all cases achieved satisfactory results, the color of the red skin lesions significantly faded, and the area of the lesions decreased noticeably. Superficial tissue ultrasound showed a reduction in lesion thickness before and after treatment. In summary, for cases where the efficacy of PWB treatment with radioactive isotope patches is inadequate, Photodynamic therapy (PDT) can be used as a treatment reference.
format Online
Article
Text
id pubmed-10315137
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103151372023-07-03 Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy Liu, Xu Yang, Lihua Zhang, Qian Yang, Fengjuan Jiang, Xian Clin Cosmet Investig Dermatol Case Series Port-wine birthmark (PWB) are congenital vascular malformations that commonly occur on the face and neck, with an incidence of 0.3–0.5% in the general population, causing significant negative psychological effects and economic burden to patients. Nevertheless, amidst the plethora of different treatment methods for PWB, choosing the option that best suits the patient’s need can be a challenge. In recent years, traditional treatment methods for PWB have been replaced by new therapies, and radioactive nuclide patch therapy is one of them. A panel of experts sought to describe herein 4 clinical cases, illustrating the PDT can demonstrate good precision and efficacy in the treatment of PWB. The research findings show the 4 patients in this group had a history of treatment with radioactive isotope patches. After 2–3 sessions of HMME-PDT, all cases achieved satisfactory results, the color of the red skin lesions significantly faded, and the area of the lesions decreased noticeably. Superficial tissue ultrasound showed a reduction in lesion thickness before and after treatment. In summary, for cases where the efficacy of PWB treatment with radioactive isotope patches is inadequate, Photodynamic therapy (PDT) can be used as a treatment reference. Dove 2023-06-28 /pmc/articles/PMC10315137/ /pubmed/37404369 http://dx.doi.org/10.2147/CCID.S418019 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Series
Liu, Xu
Yang, Lihua
Zhang, Qian
Yang, Fengjuan
Jiang, Xian
Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
title Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
title_full Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
title_fullStr Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
title_full_unstemmed Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
title_short Four Cases of Port-Wine Birthmark Treated with Hematoporphyrin Monomethyl Ether-Mediated Photodynamic Therapy After Radioactive Nuclide Patch Therapy
title_sort four cases of port-wine birthmark treated with hematoporphyrin monomethyl ether-mediated photodynamic therapy after radioactive nuclide patch therapy
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315137/
https://www.ncbi.nlm.nih.gov/pubmed/37404369
http://dx.doi.org/10.2147/CCID.S418019
work_keys_str_mv AT liuxu fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy
AT yanglihua fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy
AT zhangqian fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy
AT yangfengjuan fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy
AT jiangxian fourcasesofportwinebirthmarktreatedwithhematoporphyrinmonomethylethermediatedphotodynamictherapyafterradioactivenuclidepatchtherapy